Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries
19931.1k citationsGaby Danan, C BénichouJournal of Clinical Epidemiologyprofile →
Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge
1993433 citationsC Bénichou, Gaby Danan et al.Journal of Clinical Epidemiologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of C Bénichou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Bénichou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Bénichou more than expected).
This network shows the impact of papers produced by C Bénichou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Bénichou. The network helps show where C Bénichou may publish in the future.
Co-authorship network of co-authors of C Bénichou
This figure shows the co-authorship network connecting the top 25 collaborators of C Bénichou.
A scholar is included among the top collaborators of C Bénichou based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with C Bénichou. C Bénichou is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
May, et al.. (1996). [DISSEMINATED STEATONECROSIS, STEATONECROTIC OSTEOLYSIS AND CANCER OF THE PANCREAS. DISCUSSION OF THE WEBER-CHRISTIAN SYNDROME].. PubMed. 115. 755–71.1 indexed citations
2.
Bénichou, C. (1994). Adverse Drug Reactions: A Practical Guide to Diagnosis and Management. Medical Entomology and Zoology.34 indexed citations
Danan, Gaby & C Bénichou. (1993). Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. Journal of Clinical Epidemiology. 46(11). 1323–1330.1122 indexed citations breakdown →
5.
Bénichou, C, Gaby Danan, & Antoine Flahault. (1993). Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge. Journal of Clinical Epidemiology. 46(11). 1331–1336.433 indexed citations breakdown →
Danan, Gaby, C Bénichou, & Adrien Flahault. (1993). [Score of suspected drug-induced acute liver disorders. Presentation of an evaluation sheet].. PubMed. 17(5 Pt 2). H22–4.4 indexed citations
8.
Royer, René & C Bénichou. (1992). [International reporting of adverse drug reactions. Final report of CIOMS ADR Working Group].. PubMed. 46(3). 173–8.2 indexed citations
Bénichou, C, et al.. (1991). Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting.. PubMed. 33(3). 257–62.55 indexed citations
Bénichou, C, et al.. (1989). [Management of clinical or biological abnormalities during therapeutic trials].. PubMed. 43(6). 465–8.1 indexed citations
14.
Baumelou, A, C Bénichou, A Castot, et al.. (1989). [Drug-induced renal insufficiency. Results of consensus meetings].. PubMed. 10(3). 157–61.9 indexed citations
15.
Guillaume, J C, J C Roujeau, J. Chevrant‐Breton, et al.. (1987). [How to diagnose a cutaneous complication of a drug. Application to vascular purpura].. PubMed. 114(5). 721–4.10 indexed citations
16.
Flament, J, et al.. (1987). [Bilateral and recurrent corneal multiperforations caused by self-mutilation during an epileptic crisis].. PubMed. 87(1). 115–7.
17.
Assan, R, et al.. (1975). Phéochromocytome et cancer thyroïdien à stroma amyloïde (syndrome de Sipple). 126(1).1 indexed citations
18.
Bénichou, C, et al.. (1971). [Treatment of common rheumatoid polyarthritis with D-penicillamine. Study of a series of 22 cases].. PubMed. 122(5). 655–62.1 indexed citations
19.
Bénichou, C, et al.. (1968). [Study of the karyotype and dermatoglyphics in rheumatology].. PubMed. 35(10). 509–13.1 indexed citations
20.
Maroteaux, P, et al.. (1963). [Polydysspondylic syndrome due to 14-15 translocation and dyschondrosteosis in the same subject. Familial segregation].. PubMed. 256. 1614–6.11 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.